Related references
Note: Only part of the references are listed.Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma
David M. Cognetti et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)
Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer
Katsuhiro Yoshikawa et al.
BMC CANCER (2021)
Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFN gamma-Dependent Tumor Vessel Regression
Yutaka Kurebayashi et al.
CANCER RESEARCH (2021)
Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation
Sandeep Kumar Parvathareddy et al.
SCIENTIFIC REPORTS (2021)
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma
Makoto Tahara et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity
Hisataka Kobayashi et al.
INTERNATIONAL IMMUNOLOGY (2021)
The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors
Denisa Baci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress
Shubhankar Nath et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer
Marek Nowak et al.
CELLS (2020)
Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
Mohammad R. Siddiqui et al.
SCIENTIFIC REPORTS (2019)
Identifying markers of immune response in ovarian cancer: does PD-L1 expression meet the mark?
S. L. Gaillard et al.
ANNALS OF ONCOLOGY (2019)
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Stephanie Lheureux et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Results of a phase 2a, multicenter, open-label, study of RM-1929 photoimmunotherapy (PIT) in patients with locoregional, recurrent head and neck squamous cell carcinoma (rHNSCC).
David M. Cognetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Near-Infrared Photoimmunotherapy of Cancer
Hisataka Kobayashi et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer
Koji Teramoto et al.
LUNG CANCER (2019)
Photoimmunotherapy of Ovarian Cancer: A Unique Niche in the Management of Advanced Disease
Shubhankar Nath et al.
CANCERS (2019)
Toxicities Associated With PD-1/PD-L1 Blockade
Daniel Y. Wang et al.
CANCER JOURNAL (2018)
Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer
Tadanobu Nagaya et al.
CANCER SCIENCE (2018)
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression
Heng Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Near Infrared Photoimmunotherapy with Combined Exposure of External and Interstitial Light Sources
Yasuhiro Maruoka et al.
MOLECULAR PHARMACEUTICS (2018)
RM-1929 photo-immunotherapy in patients with recurrent head and neck cancer: Results of a multicenter phase 2a open-label clinical trial.
Ann M. Gillenwater et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Near infrared photoimmunotherapy with avelumab, an antiprogrammed death-ligand 1 (PD-L1) antibody
Tadanobu Nagaya et al.
ONCOTARGET (2017)
Metabolomic characterization of experimental ovarian cancer ascitic fluid
Santosh K. Bharti et al.
METABOLOMICS (2017)
Tumor location impacts immune response in mouse models of colon cancer
Xianda Zhao et al.
ONCOTARGET (2017)
Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity
Mikako Ogawa et al.
ONCOTARGET (2017)
The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1/PD-L1 Antibody Blockade
Howard Y. Li et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
John R. Webb et al.
GYNECOLOGIC ONCOLOGY (2016)
Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer
Toshiko Harada et al.
ONCOTARGET (2016)
Effect of Pantethine on Ovarian Tumor Progression and Choline Metabolism
Marie-France Penet et al.
FRONTIERS IN ONCOLOGY (2016)
Phototheranostics of CD44-positive cell populations in triple negative breast cancer
Jiefu Jin et al.
SCIENTIFIC REPORTS (2016)
Interferon-gamma regulates cellular metabolism and mRNA translation to potentiate macrophage activation
Xiaodi Su et al.
NATURE IMMUNOLOGY (2015)
Near Infrared Photoimmunotherapy in the Treatment of Disseminated Peritoneal Ovarian Cancer
Kazuhide Sato et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
Markus Riester et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla
Peter Stanwell et al.
INVESTIGATIVE RADIOLOGY (2008)
Expression of CD68 in non-myeloid cell types
E. Gottfried et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo
MG del Carmen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A
JR Conejo-Garcia et al.
NATURE MEDICINE (2004)
Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma
L Zhang et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Development of a syngeneic mouse model for events related to ovarian cancer
KF Roby et al.
CARCINOGENESIS (2000)
Share Paper
